JP2023553193A5 - - Google Patents
Info
- Publication number
- JP2023553193A5 JP2023553193A5 JP2023557840A JP2023557840A JP2023553193A5 JP 2023553193 A5 JP2023553193 A5 JP 2023553193A5 JP 2023557840 A JP2023557840 A JP 2023557840A JP 2023557840 A JP2023557840 A JP 2023557840A JP 2023553193 A5 JP2023553193 A5 JP 2023553193A5
- Authority
- JP
- Japan
- Prior art keywords
- aptamer
- item
- cancer
- cells
- cancer cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121080P | 2020-12-03 | 2020-12-03 | |
| US63/121,080 | 2020-12-03 | ||
| US202163257402P | 2021-10-19 | 2021-10-19 | |
| US63/257,402 | 2021-10-19 | ||
| PCT/IB2021/000849 WO2022118077A2 (en) | 2020-12-03 | 2021-12-03 | T-lymphocyte binding aptamers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553193A JP2023553193A (ja) | 2023-12-20 |
| JP2023553193A5 true JP2023553193A5 (https=) | 2024-12-11 |
| JP7837345B2 JP7837345B2 (ja) | 2026-03-30 |
Family
ID=80446452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557840A Active JP7837345B2 (ja) | 2020-12-03 | 2021-12-03 | Ｔリンパ球結合アプタマー |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12146140B2 (https=) |
| EP (1) | EP4256057A2 (https=) |
| JP (1) | JP7837345B2 (https=) |
| IL (1) | IL303374A (https=) |
| WO (1) | WO2022118077A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7837345B2 (ja) | 2020-12-03 | 2026-03-30 | アーミューン リミテッド | Ｔリンパ球結合アプタマー |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2690441A1 (en) * | 2012-07-26 | 2014-01-29 | Rheinische Friedrich-Wilhelms-Universität Bonn | Method of determining a protein in a sample |
| US11219635B2 (en) * | 2016-02-19 | 2022-01-11 | City Of Hope | Bi-specific aptamer |
| CN107129988A (zh) | 2016-02-29 | 2017-09-05 | 广西医科大学 | 一种特异性结合cd3的核酸适配体及其筛选方法和应用 |
| US11261250B2 (en) | 2016-07-22 | 2022-03-01 | Fred Hutchinson Cancer Research Center | Bi-specific molecule for cell-specific Notch inhibition and related methods and compositions |
| WO2019035763A1 (en) * | 2017-08-16 | 2019-02-21 | Agency For Science, Technology And Research | APTAMERS FOR DETECTION OF ZIKA FLAVIVIRAL PROTEIN |
| US10584340B2 (en) * | 2017-09-29 | 2020-03-10 | University Of Florida Research Foundation, Inc. | Tau protein-binding DNA aptamers with capture/detection and therapeutic utilities in tauopathy-related neurodegenerative disorders |
| WO2020065404A2 (en) | 2018-09-28 | 2020-04-02 | Augmanity Nano Ltd | Methods and compositions for selection of functional aptamers |
| CN116419763A (zh) * | 2020-05-20 | 2023-07-11 | 奥妙有限公司 | 双特异性个性化适体 |
| US20230193286A1 (en) * | 2020-05-20 | 2023-06-22 | Aummune Ltd. | Cytotoxic t-lymphocyte binding aptamers |
| JP7837345B2 (ja) | 2020-12-03 | 2026-03-30 | アーミューン リミテッド | Ｔリンパ球結合アプタマー |
-
2021
- 2021-12-03 JP JP2023557840A patent/JP7837345B2/ja active Active
- 2021-12-03 US US17/542,046 patent/US12146140B2/en active Active
- 2021-12-03 IL IL303374A patent/IL303374A/en unknown
- 2021-12-03 EP EP21854938.4A patent/EP4256057A2/en active Pending
- 2021-12-03 WO PCT/IB2021/000849 patent/WO2022118077A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dua et al. | Nucleic acid aptamers targeting cell-surface proteins | |
| US20130101506A1 (en) | Compositions comprising nucleic acid aptamers | |
| AU2013299332B2 (en) | EpCAM aptamer for detection of cancer stem cells | |
| CN109563537B (zh) | 使用核酸适体用于导向的模板化组装的方法 | |
| US10155946B2 (en) | Particle-nucleic acid conjugates and therapeutic uses related thereto | |
| PL201637B1 (pl) | Ligand tenascyny C będący kwasem nukleinowym, oczyszczony i nie występujący w przyrodzie, kompleks zawierający ligand tenascyny C i sposób wytwarzania kompleksu, oraz zastosowanie liganda tenascyny C | |
| TW201103983A (en) | Aptamer against chymase and use thereof | |
| JP2015504089A (ja) | 磁性ナノ粒子−ＳＡＭｉＲＮＡ複合体およびその製造方法 | |
| JP2016531563A (ja) | 肝臓癌関連遺伝子特異的ｓｉＲＮＡ、そのようなｓｉＲＮＡを含む二重らせんオリゴＲＮＡ構造体及びこれを含む癌予防または治療用組成物 | |
| CN116367863A (zh) | 穿透血脑屏障的适体及其用途 | |
| KR20220131621A (ko) | 압타머기반 입자 및 이의 제조방법 | |
| WO2015184224A1 (en) | Aptamer targeting mage-a3 peptide and uses thereof | |
| CN111218443B (zh) | 合成核酸药物偶联物的方法 | |
| JP2023553193A5 (https=) | ||
| KR102067675B1 (ko) | CRISP/Cas 시스템에 사용하기 위한 융합 단백질, 그를 포함하는 복합체 및 그의 용도 | |
| EP4148132A1 (en) | Novel nucleic acid ligand, and method for identifyng same | |
| JP2023527311A5 (https=) | ||
| JP2022516054A (ja) | 新規のｄｎａアプタマー及びこれの用途 | |
| WO2025124364A1 (en) | Sirna molecule for inhibiting pcsk9 expression and use thereof | |
| JP7837345B2 (ja) | Ｔリンパ球結合アプタマー | |
| TW202214861A (zh) | 針對ｉｌ－２１之適體及其用途 | |
| CN116419763A (zh) | 双特异性个性化适体 | |
| IL298354A (en) | Cytotoxic t-lymphocyte binding aptamers | |
| KR20210116861A (ko) | 압타머기반 입자 및 이의 제조방법 | |
| KR101250557B1 (ko) | Ｐａｕｆ 특이적 앱타머 및 이를 포함하는 췌장암 치료용 조성물 |